Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy

NCT00844714 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Function
Rheumatoid Arthritis
Inflammation

Interventions

DRUG: Rituxan

Sponsor

University of California, San Francisco

Collaborators

[object Object]